Frank Hsu

Director/Board Member at

Karin Grunebaum Cancer Research Foundation

65 year

92 connections

Health Technology

Consumer Services

Retail Trade

Profile

Frank J.
Hsu is a trustee at Karin Grunebaum Cancer Research Foundation.
He was a Senior Director-Medical at Genzyme Corp.
from 2002 to 2012, and Director-Immunology Research Programs at Yale Cancer Center from 1996 to 2002.
He was also a Researcher at Stanford University from 1990 to 1996.
From 2012 to 2013, he served as the Chief Medical Officer at Zyngenia, Inc. He was the Vice President & Head-Oncology at Immune Design Corp.
from 2014 to 2018.
Currently, he is the Chief Medical Officer at Oncternal Therapeutics, Inc. and the Chief Marketing Officer at Apexigen, Inc. Hsu received his undergraduate degree from Stanford University and his doctorate from Harvard Medical School.

Frank Hsu active positions

Companies	Position	Start
Karin Grunebaum Cancer Research Foundation Karin Grunebaum Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services The Karin Grunebaum Cancer Research Foundation funds cancer research focused on understanding causes, treatments, and cures, investing directly in promising researchers. The private company is based in Cambridge, MA. The foundation supports junior faculty and medical students primarily at Harvard Medical School and Boston University School of Medicine, offering fellowships, training programs, seminars, and an annual cancer research poster competition. It established the Karin Grunebaum Chair in Cancer Research at Boston University to promote interdisciplinary studies. The foundation supports research at institutions such as Dana-Farber Cancer Institute and Massachusetts General Hospital and encourages public support to further its mission.	Director/Board Member	-

All active positions of Frank Hsu

Former positions of Frank Hsu

Companies	Position	End
APEXIGEN, INC.	Chief Tech/Sci/R&D Officer	23/08/2023
IMMUNE DESIGN CORP	Corporate Officer/Principal	01/01/2018
Zyngenia, Inc. Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics	Chief Tech/Sci/R&D Officer	01/06/2013
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Chief Tech/Sci/R&D Officer	01/01/2012
Yale Cancer Center Yale Cancer Center Hospital/Nursing ManagementHealth Services Provides treatment services for cancer patients	Corporate Officer/Principal	01/01/2002

See the detail of Frank Hsu's experience

Training of Frank Hsu

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Frank Hsu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Health Technology
Zyngenia, Inc. Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics	Retail Trade
Stanford University Stanford University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Yale Cancer Center Yale Cancer Center Hospital/Nursing ManagementHealth Services Provides treatment services for cancer patients	Health Services
Immune Design Corp. Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company	Health Technology
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Karin Grunebaum Cancer Research Foundation Karin Grunebaum Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services The Karin Grunebaum Cancer Research Foundation funds cancer research focused on understanding causes, treatments, and cures, investing directly in promising researchers. The private company is based in Cambridge, MA. The foundation supports junior faculty and medical students primarily at Harvard Medical School and Boston University School of Medicine, offering fellowships, training programs, seminars, and an annual cancer research poster competition. It established the Karin Grunebaum Chair in Cancer Research at Boston University to promote interdisciplinary studies. The foundation supports research at institutions such as Dana-Farber Cancer Institute and Massachusetts General Hospital and encourages public support to further its mission.	Commercial Services
Oncternal Therapeutics, Inc. Oncternal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that manufactures pharmaceutical products	Health Technology
Apexigen, Inc. Apexigen, Inc. BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancer	Health Technology

See company connections